StreetAccount Sector Summary - Healthcare Post-Market
StreetAccount Summary - US Pre-market trading update
StreetAccount Sector Summary - Healthcare Pre-Market
Legend Biotech announces preliminary sales for CARVYKTI for the quarter ended 31-Mar-25 of ~$369M (HK$10.52, 0.00)
StreetAccount Summary - US Pre-market trading
Legend Biotech notes JNJ reported Q1 CARVYKTI net sales of $369M - 6-K ($32.11, 0.00)
Follow-up: US President Donald Trump says the US will unveil "major" tariff on imports of pharmaceutical goods - NBC News
Tuesday AM conference calls - Healthcare
Legend Biotech reports Q4 EPS ($0.15) ex-items vs FactSet ($0.25) [19 est, ($0.50)-(0.11)] ($34.03, 0.00)
Powered by FactSet Research Systems Inc.